Latest Updates

In H1FY18, net profit is recorded at Rs 15.04 crore

The first-of-its-kind device for liquid medicines provides accurate, hygienic and convenient dosing

The certification underlines the carrier’s capabilities in the treatment and transportation of high-value, time-sensitive and…

Total income declines by 9.44 per cent to Rs 796.96 crore

The Global Generics & Biosimilars Awards 2017 was held in Frankfurt, Germany

Revenue from operations was at Rs 1,115.32 crore

The consolidated total income of the company stood at Rs 4,195.74 crore

According to Biocon, it has completed the corrective and preventive actions (CAPAs), including the facility modifications, in…

The company states that it will try to resolve the issues at the earliest

Beginning on November 15, 2017, equity shares of the company will trade on the NYSE under the new name and new ticker symbol 'IQV'